Recordati Industria Chimica e Farmaceutica S.p.A.'s (BIT:REC) Share Price Could Signal Some Risk
Apr 23
Italian (Borsa Italiana) Healthcare Sector Analysis
UpdatedApr 22, 2024
DataAggregated Company Financials
Companies19
- 7D1.0%
- 3M4.5%
- 1Y4.1%
- YTD1.5%
The Healthcare is pretty flat in the last 7 days, but DiaSorin has stood out, gaining 8.5%. The past year has been better, since the industry has gained 4.1% in that time. Looking forward, earnings are forecast to grow by 11% annually.
Sector Valuation and Performance
Has the Italian Healthcare Sector valuation changed over the past few years?
| Date | Market Cap | Revenue | Earnings | PE | Absolute PE | PS |
|---|---|---|---|---|---|---|
| Tue, 23 Apr 2024 | €25.3b | €18.7b | €1.4b | 19.3x | 18.4x | 1.4x |
| Thu, 21 Mar 2024 | €25.5b | €18.6b | €1.4b | 20.3x | 18.3x | 1.4x |
| Sat, 17 Feb 2024 | €25.2b | €18.6b | €1.4b | 18.6x | 18.1x | 1.4x |
| Mon, 15 Jan 2024 | €25.3b | €18.6b | €1.4b | 18.1x | 18.2x | 1.4x |
| Wed, 13 Dec 2023 | €23.8b | €18.6b | €1.4b | 18.3x | 17.1x | 1.3x |
| Fri, 10 Nov 2023 | €22.9b | €18.6b | €1.4b | 16.9x | 16.5x | 1.2x |
| Sun, 08 Oct 2023 | €22.7b | €18.6b | €1.4b | 16.5x | 15.7x | 1.2x |
| Tue, 05 Sep 2023 | €23.8b | €17.3b | €1.1b | 16.1x | 20.9x | 1.4x |
| Thu, 03 Aug 2023 | €24.0b | €7.8b | €857.4m | 15.1x | 28x | 3.1x |
| Sat, 01 Jul 2023 | €24.3b | €7.7b | €822.5m | 17.5x | 29.5x | 3.1x |
| Mon, 29 May 2023 | €24.2b | €7.7b | €822.5m | 22.6x | 29.4x | 3.1x |
| Wed, 26 Apr 2023 | €23.7b | €7.6b | €826.9m | 21.6x | 28.6x | 3.1x |
| Fri, 24 Mar 2023 | €22.8b | €7.6b | €868.1m | 18.5x | 26.2x | 3x |
| Sun, 19 Feb 2023 | €23.9b | €7.4b | €886.1m | 24.7x | 27x | 3.2x |
| Tue, 17 Jan 2023 | €24.3b | €7.4b | €886.1m | 24.4x | 27.4x | 3.3x |
| Thu, 15 Dec 2022 | €25.3b | €7.4b | €886.1m | 23.6x | 28.5x | 3.4x |
| Sat, 12 Nov 2022 | €25.0b | €7.4b | €896.5m | 21.3x | 27.8x | 3.4x |
| Mon, 10 Oct 2022 | €21.8b | €7.3b | €908.8m | 20.1x | 24x | 3x |
| Wed, 07 Sep 2022 | €24.0b | €7.2b | €886.8m | 21.8x | 27.1x | 3.3x |
| Fri, 05 Aug 2022 | €26.6b | €7.1b | €900.9m | 23.8x | 29.5x | 3.8x |
| Sun, 03 Jul 2022 | €25.2b | €6.9b | €957.4m | 21.2x | 26.3x | 3.7x |
| Tue, 31 May 2022 | €26.4b | €7.0b | €966.7m | 22.4x | 27.3x | 3.7x |
| Thu, 28 Apr 2022 | €27.4b | €6.8b | €952.4m | 22.4x | 28.8x | 4x |
| Sat, 26 Mar 2022 | €28.3b | €6.7b | €951.9m | 22.7x | 29.8x | 4.2x |
| Mon, 21 Feb 2022 | €29.2b | €6.8b | €1.0b | 21.8x | 28.4x | 4.3x |
| Wed, 19 Jan 2022 | €33.3b | €6.8b | €1.0b | 22.3x | 32.4x | 4.9x |
| Fri, 17 Dec 2021 | €36.7b | €6.8b | €1.0b | 23.5x | 35.8x | 5.4x |
| Sun, 14 Nov 2021 | €38.3b | €6.7b | €999.9m | 27.9x | 38.3x | 5.8x |
| Tue, 12 Oct 2021 | €34.2b | €6.6b | €1.0b | 26.9x | 33.8x | 5.2x |
| Thu, 09 Sep 2021 | €38.8b | €6.6b | €1.0b | 30x | 38.2x | 5.9x |
| Sat, 07 Aug 2021 | €35.9b | €6.4b | €1.0b | 29.8x | 35.2x | 5.6x |
| Fri, 30 Apr 2021 | €30.6b | €6.1b | €925.0m | 23.4x | 33x | 5x |
Price to Earnings Ratio
33x
Current Industry PE
- Investors are pessimistic on the Italian Healthcare industry, indicating that they anticipate long term growth rates will be lower than they have historically.
- The industry is trading at a PE ratio of 18.4x which is lower than its 3-year average PE of 27.4x.
- The 3-year average PS ratio of 3.5x is higher than the industry's current PS ratio of 1.4x.
Past Earnings Growth
- The earnings for companies in the Healthcare industry have grown 14% per year over the last three years.
- Revenues for these companies have grown 46% per year.
- This means that more sales are being generated by these companies overall, and subsequently their profits are increasing too.
Industry Trends
Which industries have driven the changes within the Italian Healthcare sector?
| IT Market | -0.31% | |
| Healthcare | 0.99% | |
| Medical Equipment | 3.17% | |
| Healthcare Services | 1.27% | |
| Healthtech | -0.16% | |
| Pharma | -0.24% | |
| Life Sciences | -0.24% | |
| Biotech | -0.65% | |
Industry PE
- Investors are most optimistic about the Healthtech industry which is trading above its 3-year average PE ratio of 34.4x.
- Analysts are expecting annual earnings growth of 47.2%, which is higher than its past year's earnings decline of 56.2% per year.
Forecasted Growth
- Analysts are most optimistic on the Healthtech industry, expecting annual earnings growth of 47% over the next 5 years.
- This is better than its past earnings decline of 56% per year.
- In contrast, the Biotech industry is expected to see its earnings decline by 80% per year over the next few years.
Top Stock Gainers and Losers
Which companies have driven the market over the last 7 days?
| Company | Last Price | 7D | 1Y | Valuation | |
|---|---|---|---|---|---|
| DIA DiaSorin | €94.94 | 8.7% +€404.5m | -2.6% | PE31.7x | |
| REC Recordati Industria Chimica e Farmaceutica | €51.10 | 3.6% +€362.2m | 25.6% | PE27x | |
| AMP Amplifon | €31.57 | 1.4% +€101.6m | -4.4% | PE45.9x | |
| MDC Medica | €26.20 | 35.1% +€28.7m | 18.0% | PE37.3x | |
| PHIL Philogen | €18.15 | 0.8% +€6.0m | 20.6% | PS29.6x |
